Biopharmaceutical Invest Information

Earnings
GENFIT Announces First Half-Year 2024 Financial Results with a Corporate Update Sep 20, 2024
Companies
Bolt Biotherapeutics Welcomes Jakob Dupont, M.D., to its Board of Directors Sep 5, 2024
Stocks
Cingulate Inc. Engages In the Benzinga All Live Access Event Aug 28, 2024
Companies
Kent Kresa Concludes Tenure on MannKind Board; Steven Binder Set to Join Aug 15, 2024
Companies
SpringWorks Therapeutics Schedules Q2 2024 Earnings Call for August 7 Jul 24, 2024
Finance
Rosen Law Firm Investigates Claims Against Biomea Fusion, Inc. on Behalf of Shareholders Jun 17, 2024
Belite Bio Awarded Sakigake Designation for Its Potential Therapeutic Tinlarebant in Stargardt Disease Treatment Jun 13, 2024
Pharmaceuticals
FDA Grants Accelerated Approval to Ipsen and Genfit's Iqirvo for Liver Disease Treatment Jun 12, 2024
Pharmaceuticals
GENFIT Reaches Historic FDA Approval with Ipsen's Iqirvo® for Primary Biliary Cholangitis Jun 11, 2024
Finance
Silo Pharma Initiates $2 Million Registered Direct Offering Jun 5, 2024
Companies
Ventyx Biosciences to Engage Investors at Trio of Conferences May 17, 2024
Stocks
Ventyx Biosciences Shareholders with Losses Encouraged to Contact The Gross Law Firm for Class Action Inquiry - VTYX Mar 21, 2024
Companies
Liquidia Technologies, Inc. (LQDA) Reports Q4 Financial Disappointment, Misses Revenue Forecasts Mar 13, 2024
Companies
Cytokinetics Announces Participation in Upcoming March Investor Conferences Mar 5, 2024
Companies
Arcutis Biotherapeutics to Present at the TD Cowen 44th Annual Health Care Conference Feb 29, 2024
Stocks
Ardelyx Inc. Receives Downgrade to Sell by StockNews.com Feb 27, 2024
Companies
Cytokinetics Set to Reveal Q4 Financial Results on February 27, 2024 Feb 14, 2024
Stocks
Navigating the Futures Market Heat: Spotlight on 5 Stocks Ready for Action Feb 12, 2024
Companies
Anavex Life Sciences Secures U.S. Patent for Blarcamesine in Neurodevelopmental Disorder Treatment Jan 9, 2024
Markets
SpringWorks Therapeutics Announces Presentation at J.P. Morgan Healthcare Conference Dec 21, 2023
Companies
Setback for Mirum Pharmaceuticals as Livmarli Fails in Mid-Stage Study for Biliary Atresia Dec 20, 2023
Biopharmaceutical
GENFIT Foresees Growth with Elafibranor Approvals for PBC Across US and Europe Dec 9, 2023
Analysis
Abeona Therapeutics Receives Sell Rating Amidst Stock Performance Scrutiny Nov 15, 2023
Companies
atai Life Sciences Reports Q3 Earnings and Financial Health Nov 14, 2023
Stocks
StockNews.com Begins Coverage on Brooklyn ImmunoTherapeutics (NYSE:BTX) Nov 13, 2023
Stocks
StockNews.com Issues a Sell Rating for Minerva Neurosciences Amid Institutional Trading Activity Nov 12, 2023
Stocks
TG Therapeutics TGTX Upgraded to 'Buy' by StockNews.com Amid Positive Analyst Sentiment Nov 12, 2023
Stocks
Sangamo Therapeutics (NASDAQ:SGMO) Receives New Coverage From StockNews.com Amid Financial Analysis From Significant Players Nov 12, 2023
Stocks
Xencor Receives Upgrade by StockNews.com to Hold Status Amid Analyst Reviews Nov 12, 2023
Investment
Intellia Therapeutics Surpasses Q3 Earnings Expectations and Announces Progress in Gene-Editing Pipeline Nov 11, 2023
Earnings
Immunovant Surpasses Q2 Earnings Expectations with a Strong Focus on Future Pipeline Nov 10, 2023
Earnings
GENFIT Announces Q3 2023 Financial Results with Cash Reserves and Revenue Insights Nov 10, 2023
Stocks
Ventyx Biosciences Shows Turnaround Signs Amid Oversold Conditions Nov 10, 2023
Ventyx Biosciences, Inc. (VTYX) Anticipates Reversal After a Significant Drop Nov 10, 2023
GH Research Advances Clinical Trials for GH001 in the Fight Against Treatment-Resistant Depression Nov 9, 2023
GH Research Announces Clinical Progress and Path Forward for GH001 in the Battle Against Treatment-Resistant Depression Nov 9, 2023
GH Research Advances Clinical Development for GH001 in Treatment-Resistant Depression Nov 9, 2023